Rate of complete metabolic responses to immune checkpoint inhibitors in extremely heavily pre-treated patients with classical Hodgkin’s lymphoma and immunoepigenetic priming.

Lorenzo Falchi,Ahmed Sawas,Changchun Deng,Jennifer E. Amengual,Donald Steven Colbourn,Emily Lichtenstein,Karen Khan,Michael J. Smith,Heather Dials,Owen A. OConnor

Rate of complete metabolic responses to immune checkpoint inhibitors in extremely heavily pre-treated patients with classical Hodgkin’s lymphoma and immunoepigenetic priming.

2016

Lorenzo Falchi
Ahmed Sawas
Changchun Deng
Jennifer E. Amengual
Donald Steven Colbourn
Emily Lichtenstein
Karen Khan
Michael J. Smith
Heather Dials
Owen A. OConnor

e19012Background: Options for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) after failure of brentuximab vedotin (Bv) and ASCT are limited. cHL is associated with genetically determine...

Keywords:

Immunology
Classical Hodgkin's Lymphoma
Priming (psychology)
Pathology
Medicine
Immune checkpoint
Brentuximab vedotin
Refractory
immune checkpoint inhibitors
Classical Hodgkin lymphoma
Cancer research

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations